Following is a list of active clinical trials involving Brainsway Deep TMS for major depressive disorder.
Active Trials for Major Depressive Disorder
Neural Predictors and Longitudinal Neural Correlates of Clinical Improvement after Standard or Deep Transcranial Magnetic Stimulation in Major Depression: A Randomized Study
McGill University Hospital, Montreal, Canada
7 July 2013Read More
Evaluation of the H1-Coil Transcranial Magnetic Stimulation (TMS) Device – Safety and Feasibility study for Treatment of Major Depressive Episode in the elderly
Shalvata Mental Health Center, Israel
11 March 2012
The purpose of this study is to evaluate the safety and anti-depressive response of the H1 Coil TMS Device in elderly patients suffering from major depressive episode.
A randomized, sham-controlled trial is now conducted at Shalvata Mental-Health Center. Its aim is to evaluate the efficacy and safety of H1-coil Deep TMS in subjects with Major Depression, currently treated by mood stabilizers.
A Randomized Sham-Controlled Study of H-Coil Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Late-Life Depression
University of Toronto, Faculty of Medicine, Centre for Addiction & Mental Health, Canada
20 March 2013Read More